STAT3 and breast carcinoma: In vitro efficacy and selectivity screening revealed that crispene E was significantly toxic towards the STAT3-positive human breast cancer cell line MDA-MB-231, with an EC50 of 5.35 μM, but had no effect against the STAT3-null human leukoblastic leukaemia cell line A4 [159].